The Obama administration's objection to the brand-name biotech drug protections in the healthcare reform bill has officially pissed off PhRMA.
The drug industry is threatening to end its support for President Barack Obama's health overhaul effort because of a rift with the administration over protecting brand-name biotech drugs from low-cost generic competitors.
Check this out:
"Please activate immediately all of your contacts," said the e-mail from Billy Tauzin, the group's president.
You know what that is? It's corporate lobbyist language for, "To war!"